Transcriptional CCND1 expression as a predictor of poor response to neoadjuvant chemotherapy with trastuzumab in HER2-positive/ER-positive breast cancer.
published in: Breast Cancer Research and Treatment
date of publication: 2014-09-09
language: English
main subject: chemotherapy, trastuzumab
Cites articles 35
Date
Title
Article - wd:Q54324226